Ayala Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Ayala Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q3 2019 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2023 was $180K.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $180K Dec 31, 2023 10-K 2024-04-16
Q3 2023 $1.87M Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $1K* -$19K -95% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2M +$1.97M +7043% Mar 31, 2023 10-Q 2023-05-23
Q2 2022 $20K Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $28K Apr 30, 2022 10-Q 2022-06-08
Q4 2021 $35K -$6.71M -99.5% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $41K -$7.02M -99.4% Oct 31, 2021 10-K 2022-02-14
Q4 2020 $6.74M -$1.26M -15.7% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $7.07M -$1.23M -14.9% Oct 31, 2020 10-K 2021-01-22
Q2 2020 $7.38M Jul 31, 2020 10-Q 2020-09-10
Q1 2020 $7.69M Apr 30, 2020 10-Q 2020-06-11
Q4 2019 $8M Jan 31, 2020 10-Q 2020-03-13
Q3 2019 $8.3M Oct 31, 2019 10-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.